Preventing Cardiovascular Complications of Type 2 Diabetes - Volume II

3,811
Total downloads
14k
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Published on 18 Jul 2025

Association of estimated glucose disposal rate with atrial fibrillation, heart failure and cardiovascular mortality in patients with diabetes: a prospective cohort study from the UK Biobank

Zhen Tan
Yijun Liu
Lei Liu
Shuang Li
Xinrui Xue
Xiaoping Li
Hongqiang Ren

doi 10.3389/fendo.2025.1579836

709 views

REVIEW

Published on 07 Jul 2025

A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review

David Aristizábal-Colorado
David Corredor-Rengifo
Santiago Sierra-Castillo
Carolina López-Corredor
David-Alexander Vernaza-Trujillo
Danilo Weir-Restrepo
Juan S. Izquierdo-Condoy
Esteban Ortiz-Prado
Jorge Rico-Fontalvo
2 more
Wilfredo-Antonio Rivera-Martínez

doi 10.3389/fendo.2025.1605746

2,500 views

ORIGINAL RESEARCH

Published on 25 Jun 2025

Establishment of a synthetic ECV model and its prognostic value in diabetes patients with acute myocardial infarction

Lei Chen
Bowen Qiu
Xinjia Du
Jiahua Liu
Yuan Lu
Wenliang Che
Wensu Chen

doi 10.3389/fendo.2025.1534236

754 views

ORIGINAL RESEARCH

Published on 19 Jun 2025

Association between glycemia risk index and carotid intima-media thickness in type 2 diabetes

Lingyun Zhao
Hongyan Heng
Qinyuan Xie
Chenghong Liang
Sijia Guo
Ziyi Zhang
Huijuan Yuan

doi 10.3389/fendo.2025.1563734

728 views

REVIEW

Published on 10 Jun 2025

Evaluation of three mechanisms of action (SGLT2 inhibitors, GLP-1 receptor agonists, and sulfonylureas) in treating type 2 diabetes with heart failure: a systematic review and network meta-analysis of RCTs

Huize Gao
Qian Wei
Anqi Zou
Keying Yu
Da Song
Jian Li
Huize Han
Aidong Liu

doi 10.3389/fendo.2025.1562815

2,835 views

ORIGINAL RESEARCH

Published on 21 Feb 2025

The triglyceride–glucose index is a promising predictor for the risk of cardiovascular disease in the diabetic population aged ≥60 years in the United States: a retrospective cohort study from NHANES (2007-2016)

Shu Yang
Zhenwei Wang

doi 10.3389/fendo.2025.1475590

2,272 views

Share on

Frontiers in Endocrinology

Cardiovascular Endocrinology
Renal Endocrinology

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

14kTopic views
9,562Article views
3,811Article downloads

View impact

Articles

Association of estimated glucose disposal rate with atrial fibrillation, heart failure and cardiovascular mortality in patients with diabetes: a prospective cohort study from the UK Biobank

A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review

Establishment of a synthetic ECV model and its prognostic value in diabetes patients with acute myocardial infarction

Association between glycemia risk index and carotid intima-media thickness in type 2 diabetes

Evaluation of three mechanisms of action (SGLT2 inhibitors, GLP-1 receptor agonists, and sulfonylureas) in treating type 2 diabetes with heart failure: a systematic review and network meta-analysis of RCTs

The triglyceride–glucose index is a promising predictor for the risk of cardiovascular disease in the diabetic population aged ≥60 years in the United States: a retrospective cohort study from NHANES (2007-2016)

Frontiers in Endocrinology

Cardiovascular Endocrinology

Renal Endocrinology